June 11, 2026
Rose
Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out diseases or trigger a rush toward enhancement.
from NYT > Health https://ift.tt/cnO4VRL
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment